KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Recursion Pharmaceuticals (RXRX) Return on Assets (2021 - 2025)

Recursion Pharmaceuticals (RXRX) has disclosed Return on Assets for 5 consecutive years, with 0.45% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets fell 2.0% year-over-year to 0.45%, compared with a TTM value of 0.45% through Dec 2025, down 2.0%, and an annual FY2025 reading of 0.44%, changed 0.0% over the prior year.
  • Return on Assets was 0.45% for Q4 2025 at Recursion Pharmaceuticals, up from 0.53% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.21% in Q3 2021 and bottomed at 0.58% in Q1 2024.
  • Average Return on Assets over 5 years is 0.41%, with a median of 0.41% recorded in 2023.
  • The sharpest move saw Return on Assets dropped -20bps in 2024, then rose 17bps in 2025.
  • Year by year, Return on Assets stood at 0.29% in 2021, then dropped by -30bps to 0.37% in 2022, then tumbled by -36bps to 0.51% in 2023, then grew by 17bps to 0.43% in 2024, then fell by -5bps to 0.45% in 2025.
  • Business Quant data shows Return on Assets for RXRX at 0.45% in Q4 2025, 0.53% in Q3 2025, and 0.5% in Q2 2025.